SCHEMBL4127785

SCHEMBL4127785

Cc1cc(C2CCCCCC2=O)ccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 1/20 0.38
KMT2A Q03164 1/20 0.37
HCAR1 Q9BXC0 2/20 0.36
UHRF1 Q96T88 1/20 0.35
USP30 Q70CQ3 1/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PROKR1 Q8TCW9 1/20 0.34
MAPK1 P28482 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
IDO1 P14902 1/20 0.34
SRC P12931 1/20 0.33
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32
CYP2C19 P33261 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30792330 0.80 TLR4 (0.39) TLR4KMT2AHCAR1ALDH1A1KDM4E
SCHEMBL10372172 0.78 MAPK1 (0.39) TLR4HCAR1ALDH1A1MAPK1CA1
SCHEMBL9013833 0.75 ALDH1A1 (0.36) TLR4KMT2AHCAR1ALDH1A1KDM4E
SCHEMBL22402327 0.75 IDO1 (0.44) KMT2AUHRF1USP30ALDH1A1KDM4E
SCHEMBL3438253 0.75 DDB1 (0.50) TLR4KMT2AHCAR1ALDH1A1CA1
SCHEMBL31615356 0.74 HCAR1 (0.41) TLR4KMT2AHCAR1ALDH1A1LMNA
SCHEMBL12093743 0.73 IDO1 (0.45) UHRF1USP30ALDH1A1KDM4EL3MBTL1
SCHEMBL11060295 0.73 CYP19A1 (0.44) KMT2AALDH1A1L3MBTL1
SCHEMBL4129415 0.73 PDE4A (0.50) KMT2AALDH1A1KDM4EMAPK1CYP3A4
SCHEMBL4129464 0.72 IDO1 (0.37) KMT2AUSP30ALDH1A1KDM4EPROKR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436005-B2 Macrocyclic pyrimidine derivatives ABBOTT LABORATORIES (US) 2013-05-07 US disclosed
WO-2009123967-A1 5,6,7,8-TETRAHYDROQUINAZOLIN-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS HISTAMINE H4 RECEPTOR MODULATORS FOR THE TREATMENT OF ASTHMA ABBOTT LABORATORIES (US) 2009-10-08 WO disclosed
US-20090253678-A1 MACROCYCLIC PYRIMIDINE DERIVATIVES ABBOTT LABORATORIES (US) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253678-A1 MACROCYCLIC PYRIMIDINE DERIVATIVES DPYD, TYMS, TYMP TLR4 4349/4885KMT2A 2893/4885HCAR1 2318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.